Epigral Limited (NSE:EPIGRAL)

Market Cap	45.97B
Revenue (ttm)	24.67B +8.5%
Net Income (ttm)	4.02B +37.1%
EPS (ttm)	93.51 +32.4%
Shares Out	43.14M
PE Ratio	11.40
Forward PE	15.35
Dividend	7.00 (0.66%)
Ex-Dividend Date	n/a

Volume	21,270
Average Volume	64,830
Open	1,069.80
Previous Close	1,065.60
Day's Range	1,045.00 - 1,069.80
52-Week Range	1,047.60 - 2,114.00
Beta	-0.23
RSI	24.27
Earnings Date	Jan 30, 2026

About Epigral

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins and compounds, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agroc...

• Industry: Chemicals
• Sector: Materials
• Founded: 2007
• Employees: 1,072
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: EPIGRAL

Financial Performance

In 2024, Epigral's revenue was 25.50 billion, an increase of 32.19% compared to the previous year's 19.29 billion. Earnings were 3.58 billion, an increase of 82.62%.